| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
6ß4 Integrin Is Associated with a High Risk for Malignant Progression in Mouse Skin Carcinogenesis1
Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892
Enhanced expression of the
6ß4 integrin complex has been linked to malignant progression in mouse skin carcinogenesis. To determine if
6ß4 expression can predict risk for malignant conversion among populations of benign skin tumors, we analyzed the distribution of
6ß4 and other markers of progression in papillomas at high and low risk for malignant progression. After initiation with 7,12-dimethylbenz[a]anthracene, mice were promoted with 12-O-tetradecanoylphorbol-13-acetate to induce predominantly low risk tumors or promoted with mezerein to produce predominantly high risk tumors. When tumors first appeared at 8 weeks after promotion, high risk papillomas demonstrated basal and suprabasal
6ß4 expression, loss of keratin 1, and aberrant expression of keratin 13. In these tumors
6ß4 expression coincided with an expansion of the proliferating compartment as indicated by suprabasal bromodeoxyuridine labeling. In contrast,
6ß4 immunostaining was confined to basal cells in low risk tumors, keratin 1 was abundant, and keratin 13 was absent in the majority of this group, while proliferating cells were largely in the basal compartment. By 33 weeks,
6ß4 suprabasal expression continued to distinguish groups at higher risk for malignant conversion, but keratin 13 was expressed in all groups. At this time, high risk tumors displayed focal expression of keratin 8 and
-glutamyltranspeptidase, markers also found in chemically induced carcinomas. Keratin 8 and
-glutamyltranspeptidase were expressed only in
6ß4 positive cells. These results indicate that expression of
6ß4 integrin in suprabasal strata serves as an early predictive marker to identify benign squamous tumors at high risk for malignant progression.
1 This work was supported by a grant from Johnson and Johnson, Consumer Products.
2 To whom requests for reprints should be addressed, at Building 37, Room 3B25, Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, MD 20892.
Received 4/ 2/93. Accepted 8/11/93.
This article has been cited by other articles:
![]() |
M. Chen, M. Sinha, B. A. Luxon, A. R. Bresnick, and K. L. O'Connor Integrin {alpha}6{beta}4 Controls the Expression of Genes Associated with Cell Motility, Invasion, and Metastasis, Including S100A4/Metastasin J. Biol. Chem., January 16, 2009; 284(3): 1484 - 1494. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Raymond, M. Kreft, J.-Y. Song, H. Janssen, and A. Sonnenberg Dual Role of {alpha}6beta4 Integrin in Epidermal Tumor Growth: Tumor-suppressive Versus Tumor-promoting Function Mol. Biol. Cell, November 1, 2007; 18(11): 4210 - 4221. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Loomis, S. Zhu, K. Yoon, P. F. Johnson, and R. C. Smart Genetic Ablation of CCAAT/Enhancer Binding Protein {alpha} in Epidermis Reveals Its Role in Suppression of Epithelial Tumorigenesis Cancer Res., July 15, 2007; 67(14): 6768 - 6776. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Pegtel, A. Subramanian, T.-S. Sheen, C.-H. Tsai, T. R. Golub, and D. A. Thorley-Lawson Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis J. Virol., December 15, 2005; 79(24): 15430 - 15442. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bertotti, P. M. Comoglio, and L. Trusolino {beta}4 Integrin Is a Transforming Molecule that Unleashes Met Tyrosine Kinase Tumorigenesis Cancer Res., December 1, 2005; 65(23): 10674 - 10679. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hintermann, N. Yang, D. O'Sullivan, J. M. G. Higgins, and V. Quaranta Integrin {alpha}6{beta}4-erbB2 Complex Inhibits Haptotaxis by Up-regulating E-cadherin Cell-Cell Junctions in Keratinocytes J. Biol. Chem., March 4, 2005; 280(9): 8004 - 8015. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Woodworth, E. Michael, L. Smith, K. Vijayachandra, A. Glick, H. Hennings, and S. H. Yuspa Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte Carcinogenesis, September 1, 2004; 25(9): 1771 - 1778. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Owens, M. R. Romero, C. Gardner, and F. M. Watt Suprabasal {alpha}6{beta}4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGF{beta} signalling J. Cell Sci., September 15, 2003; 116(18): 3783 - 3791. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Owens and F. M. Watt Influence of {beta}1 Integrins on Epidermal Squamous Cell Carcinoma Formation in a Transgenic Mouse Model: {{alpha}}3{beta}1, but not {{alpha}}2{beta}1, Suppresses Malignant Conversion Cancer Res., July 1, 2001; 61(13): 5248 - 5254. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alt, M. Ohba, L. Li, M. Gartsbein, A. Belanger, Mitchell. F. Denning, T. Kuroki, S. H. Yuspa, and T. Tennenbaum Protein Kinase C{{delta}}-mediated Phosphorylation of {{alpha}}6{beta}4 Is Associated with Reduced Integrin Localization to the Hemidesmosome and Decreased Keratinocyte Attachment Cancer Res., June 1, 2001; 61(11): 4591 - 4598. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Wertheimer, N. Spravchikov, M. Trebicz, M. Gartsbein, D. Accili, I. Avinoah, S. Nofeh-Moses, G. Sizyakov, and T. Tennenbaum The Regulation of Skin Proliferation and Differentiation in the IR Null Mouse: Implications for Skin Complications of Diabetes Endocrinology, March 1, 2001; 142(3): 1234 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Witkowski, G.T. Bowden, R. B. Nagle, and A. E. Cress Altered surface expression and increased turnover of the {alpha}6{beta}4 integrin in an undifferentiated carcinoma Carcinogenesis, February 1, 2000; 21(2): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhu, H.-S. Oh, M. Shim, E. Sterneck, P. F. Johnson, and R. C. Smart C/EBPbeta Modulates the Early Events of Keratinocyte Differentiation Involving Growth Arrest and Keratin 1 and Keratin 10 Expression Mol. Cell. Biol., October 1, 1999; 19(10): 7181 - 7190. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Owens, S.-J. C. Wei, and R. C. Smart A multihit, multistage model of chemical carcinogenesis Carcinogenesis, September 1, 1999; 20(9): 1837 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Takaoka, T. Yamada, M. Gotoh, Y. Kanai, K. Imai, and S. Hirohashi Cloning and Characterization of the Human beta 4-Integrin Gene Promoter and Enhancers J. Biol. Chem., December 11, 1998; 273(50): 33848 - 33855. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Giancotti Signal transduction by the alpha 6 beta 4 integrin: charting the path between laminin binding and nuclear events J. Cell Sci., January 6, 1996; 109(6): 1165 - 1172. [PDF] |
||||
![]() |
B. F. Trump Mechanisms of Toxicity and Carcinogenesis Toxicol Pathol, November 1, 1995; 23(6): 775 - 827. [PDF] |
||||
![]() |
A B Glick, M M Lee, N Darwiche, A B Kulkarni, S Karlsson, and S H Yuspa Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. Genes & Dev., October 15, 1994; 8(20): 2429 - 2440. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |